Bill
HB 4771
The bill tightens who can access West Virginia’s CSMP records, establishing clearer access criteria, privacy protections, and accountability to safeguard sensitive data.
HB 4771 (West Virginia, 2026) – Relating to access of records in controlled substance monitoring
Overview
- Purpose: To regulate who can access records maintained under West Virginia’s Controlled Substances Monitoring Program (CSMP) and to specify the circumstances and procedures for obtaining access to those records.
- Session and status: 2026 session; introduced January 23, 2026; assigned to Health and Human Resources and introduced in the House. (Action history shows initial filing and committee assignment; no final passage data provided.)
Key Provisions and Changes
- Access to CSMP records: The bill focuses on clarifying and potentially narrowing or outlining the entities and individuals who may request and obtain access to CSMP records. While the full text is not provided here, the emphasis is on access controls and processes.
- Justification for access: It is likely to set criteria for legitimate purposes for accessing CSMP data (e.g., clinical care, law enforcement with proper authorization, licensing and regulatory activities, medical or prescription oversight).
- Safeguards and privacy: The bill would address privacy protections, limitations on use and disclosure, and retention or handling requirements for CSMP data to minimize misuse.
- Personnel and accountability: Potential requirements for responsibilities of personnel who handle CSMP records, including training, auditing, and accountability measures for unauthorized access.
- Compliance and enforcement: Provisions may include penalties or corrective actions for violations of access restrictions, as well as processes for monitoring compliance.
Who Would Be Affected
- Healthcare providers and prescribers: Likely subject to defined access rights to CSMP records for patient care, monitoring, or treatment decisions.
- Pharmacists and dispensing entities: May require access to verify controlled substance dispensing information for patient safety and regulatory compliance.
- Regulatory and licensing bodies: May obtain CSMP access for oversight, licensing determinations, or investigations.
- Law enforcement and public health entities: Access could be allowed under specific legal processes (e.g., with warrants or statutory authorization), subject to privacy protections.
- Patients and the general public: Indirectly affected through strengthened privacy safeguards and clearer rules governing who can view their CSMP data.
Procedural and Timeline Aspects
- Introduction and committee referral: Filed January 23, 2026; referred to House Health and Human Resources. The legislative process would proceed through standard committee hearings, potential amendments, and votes before advancing to floor consideration.
- Implementing timeline: If enacted, the bill would establish effective dates for any new access rules, implementation timelines for agencies, and any transitional provisions (e.g., phased rollout or grace periods for ongoing access requests).
Notes and Considerations
- The provided text appears to be an incomplete excerpt or a data artifact; the full bill language would specify exact eligible users, permissible uses, scope of records, privacy protections, appeal processes, and any exemptions.
- Readers should consult the official bill text for precise definitions (e.g., “CSMP records,” “access,” “authorized entities”), timing, and enforcement mechanisms, as well as any amendments adopted during committee or floor debates.
If you’d like, I can tailor this summary once the formal bill language is available, or produce a side-by-side comparison with current law and notable proposed changes.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
